Biotech

SolasCure Receives FDA Fast Track Designation for Aurase Wound Gel in Treatment of Calciphylaxis Ulcers

Designation underscores potential to address critical unmet need in rare and life-threatening wound condition.

One Million New Species Discovered

Basecamp Research has announced the discovery of over one million previously unknown species as part of their new BaseData™ dataset.

SpliceBio Raises €130M Series B to Advance Stargardt Gene Therapy and Expand Genetic Medicines

SpliceBio has raised €130M in Series B funding to advance its gene therapy for Stargardt disease and expand its pipeline using a proprietary protein splicing platform.

Shift Bioscience Unveils Breakthrough Single-Gene Target for Safe Cellular Rejuvenation

SB000 reverses cellular aging across multiple cell types without triggering risky pluripotency pathways.

PeproMene Bio Reports Complete Remission in First Follicular Lymphoma Patient from Phase 1 Trial

BAFFR-targeted CAR T cell therapy shows promise in treating relapsed follicular lymphoma.

Using Jumping Genes for Safer, More Accurate DNA Editing

Researchers have developed a new gene-editing technique called bridge editing, which uses bacterial "jumping genes" to precisely insert large DNA sequences into the human genome without causing harmful DNA breaks, offering a safer and more efficient method for treating genetic disorders.